Evidence map›Paper›PMID 30987188›Full record

ArticleInternational journal of molecular sciences2019

Silver and Copper Nanoparticles-An Alternative in Future Mastitis Treatment and Prevention?

Aleksandra Kalińska, Sławomir Jaworski, Mateusz Wierzbicki, Marcin Gołębiewski

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aleksandra KalińskaCattle Breeding Division; Warsaw University of Life Sciences, Ciszewskiego 8 street, 02-786 Warsaw, Poland. aleksandra_kalinska@sggw.pl.ORCID 0000-0001-5861-0635
Sławomir JaworskiDivision of Nanobiotechnology; Warsaw University of Life Sciences, Ciszewskiego 8 street, 02-786 Warsaw, Poland. slawomir_jaworski@sggw.pl.
Mateusz WierzbickiDivision of Nanobiotechnology; Warsaw University of Life Sciences, Ciszewskiego 8 street, 02-786 Warsaw, Poland. mateusz_wierzbicki@sggw.pl.ORCID 0000-0003-3623-8929
Marcin GołębiewskiCattle Breeding Division; Warsaw University of Life Sciences, Ciszewskiego 8 street, 02-786 Warsaw, Poland. marcin_golebiewski@sggw.pl.
Warsaw University of Life Sciences · PL

Funding

National Centre for Research and Development LIDER/6/0070/L-7/15/NCBR/2016
6 · The paper itself

Abstract

Nowadays, mastitis is one of the biggest problems in breeding dairy cattle. Treatment of this disease with conventional antibiotics is ineffective because many pathogens are resistant. Researchers have therefore been forced to look for new solutions, and metal nanoparticles (NPs) have been found to be the most appropriate agents. This study uses commercially available silver (AgNPs) and copper (CuNPs) nanoparticles and synthetized silver-copper nanoparticles (AgCuNPs) to evaluate the effect of these NPs on human and bovine mammary cells. The effect of AgNPs, CuNPs, and AgCuNPs on pathogen species commonly involved in udder inflammation (e.g.,

Indexed as

AnimalsBacteriaCattleCell LineCell MembraneCell SurvivalCopperEpithelial CellsFemaleFungiHumansMastitisMetal NanoparticlesOxidation-ReductionParticle SizeSilverCopperSilvercoppermastitis pathogensnanoparticlessilver

Identifiers

PMID30987188
PMCPMC6480535
OpenAlexW2934134386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.